Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_107683.htm |
| EX-32.2 - EXHIBIT 32.2 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_107685.htm |
| EX-32.1 - EXHIBIT 32.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_107684.htm |
| EX-31.1 - EXHIBIT 31.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_107682.htm |
| EX-24.1 - EXHIBIT 24.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_107681.htm |
| EX-23.1 - EXHIBIT 23.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_107679.htm |
| EX-21.1 - EXHIBIT 21.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | ex_107678.htm |
| 10-K - FORM 10-K - NAVIDEA BIOPHARMACEUTICALS, INC. | navb20171231_10k.htm |
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
Navidea Biopharmaceuticals, Inc.
Dublin, Ohio
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-222092) and Form S-8 (No. 333-119219, 333-130636, 333-130640, 333-153110, 333-158323, 333-183317, 333-198716 and 333-217814) of Navidea Biopharmaceuticals, Inc. of our report dated March 23, 2016, relating to the consolidated financial statements of Navidea Biopharmaceuticals, Inc., which appears in this Form 10-K.
/s/ BDO USA, LLP
Chicago, Illinois
March 15, 2018